Schedule 13D ownership disclosure

Nautilus Biotechnology, Inc.

Security class unavailable · CUSIP: 63909J108

Event date: 2021-06-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
16,008,410
Percent of class
12.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-087437
Form type
SC 13D
Filer
AH Bio Fund II, L.P.
CIK
CIK 1725721
Filed
Jun 30, 2021
Reporting period
Jun 09, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub